Abiopharma

(99% Neutral) Abcam Plc (ABCM) Announces 2022 Annual General Meeting

(10% Negative) AVROBIO, INC. (AVRO) Announces Delay in trial Trials for Pompe disease Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(10% Negative) Legend Biotech (LEGN) Announces Clinical Development Update (Form 6-K)

(88% Positive) APPLIED MOLECULAR TRANSPORT INC. (AMTI) Provides Update on steps for AMT-126

(80% Positive) Poseida Therapeutics, Inc. (PSTX) Announces Regulatory Update

(10% Negative) SELECTA BIOSCIENCES, INC. (SELB) Announces Business Combination

(99% Neutral) Cytokinetics, Incorporated (CYTK) Announces Clinical Development Update

(10% Negative) PASSAGE BIO, INC. (PASG) Announces Delay in offers Trials for Washington Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update

(90% Positive) Axsome Therapeutics, Inc. (AXSM) Announces Enrollment Update for Institute Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment